Evidence map›Paper›PMID 37533786›Full record

ArticleRSC advances2023

Analytical study of gold-DNA nano core-shell cloaking characteristics for drug delivery and cancer therapy.

Nahid Osanloo, Vahid Ahmadi, Mohammad Naser-Moghaddasi, Elham Darabi

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nahid OsanlooFaculty of Engineering, Science and Research Branch, Islamic Azad University Tehran Iran.ORCID https://orcid.org/0000-0002-5867-7765
Vahid AhmadiDepartment of Electrical and Computer Engineering, Tarbiat Modares University Tehran Iran v_ahmadi@modares.ac.ir.ORCID https://orcid.org/0000-0002-4131-2153
Mohammad Naser-MoghaddasiFaculty of Engineering, Science and Research Branch, Islamic Azad University Tehran Iran.
Elham DarabiPlasma Physics Research Center, Science and Research Branch, Islamic Azad University Tehran Iran.
Islamic Azad University, Science and Research Branch · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cloaking characteristics of biocells can be considered as a factor to determine drug absorption by the tissues. The metal-organic core-shell structure can act as a cloak around the molecules of tissue and can be used as a nanomachine for drug delivery. Thus, we define a ratio of drug absorption based on frequency red-shift and the effective permittivity in the optical spectrum. Here, a cylinder of molecules coated by plasmonic nano core-shells is proposed for measuring the cloaking characteristics of biocells. The overall bandwidth of the proposed cloak for reflectance less than -10 dB is 36%. We check the effect of the filling factors of nanoparticles on the reflection and the frequency response of the tissue. Besides the frequency red-shift and change in the level of reflection, the phase and impedance are extracted. We could obtain the normalized scattering cross-section of 5 dB lower than the cylinder without cloak for the cylinder with a gold-DNA core-shell cloak. Here, we modify the Maxwell-Garnett equation for a cylindrical structure to obtain the effective value of the permittivity for cancer and normal tissues. The results show that obtained permittivity from the simulation has a good match with the calculated permittivity from the Maxwell-Garnet equation. Therefore, this approach can be considered as an efficient method for drug absorption and diagnosis of cancer cells from normal cells.

Identifiers

PMID37533786
PMCPMC10392965
OpenAlexW4385467912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.